Clinical Trial Update: Hepatocellular Carcinoma Identification Using Delta-HLD

View source ↗

Summary

A clinical trial update notes a study evaluating Delta-HLD for identification of hepatocellular carcinoma, which is currently recruiting and sponsored by Epiliq…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Delta-HLD

Snippet

Sponsor: Epiliquid Holding, Inc | Conditions: Hepato Cellular Carcinoma (HCC) | Status: RECRUITING